ACTOBIOTICS®: MICROBE-BASED PHARMACEUTICAL AGENTS

for expression and local delivery of therapeutics at disease sites

including the intestine, the mouth and the nasopharynx.

NEWS

ActoBio Therapeutics™ Presented at Biotech Showcase 2019 - Download Chief Executive Officer Pieter Rottiers’ presentation on the innovative ActoBiotics® platform and its applications.

PRODUCTS

ActoBio Therapeutics™ has a rich pipeline of therapeutic agents, called ActoBiotics®, that are developed to treat a number of diseases, focusing primarily on disease areas with high unmet needs in immunotherapy, allergy and immune tolerance induction.

PLATFORM

ActoBiotics® are based on the well-characterized, safe food-grade bacterium Lactococcus lactis. They are specifically designed and engineered to perform very specific biological interventions across broad therapeutic applications.

clinical and
developmental
pipeline